Transcriptional regulation in the rat prefrontal cortex and hippocampus after a single administration of psilocybin
The DOI matches its Crossref record; 71 of the 71 references it cites were found in a registry or an index.
Abstract
Background: Psilocybin is a serotonergic psychedelic found in “magic mushrooms” with a putative therapeutic potential for treatment-resistant depression, anxiety, obsessive-compulsive disorder, and addiction. In rodents, psilocybin acutely induces plasticity-related immediate early genes in cortical tissue; however, studies into the effects on subcortical regions, of different doses, and the subsequent translation of corresponding proteins are lacking. Methods: We examined the acute effects of a single administration of psilocybin (0.5–20 mg/kg) on the expression of selected genes in the prefrontal cortex and hippocampus. In total, 46 target genes and eight reference genes were assessed using real-time quantitative polymerase chain reaction. Corresponding protein levels of the three most commonly regulated genes were assessed using Western blotting. Results: In the prefrontal cortex, psilocybin increased the expression of Cebpb, c-Fos, Dups1, Fosb, Junb, Iκβ-α, Nr4a1, P11, Psd95, and Sgk1, and decreased the expression of Clk1. In the hippocampus, psilocybin strongly increased the expression of Arrdc2, Dusp1, Iκβ-α, and Sgk1 in a dose-dependent manner, and decreased the expression of Arc, Clk1, Egr2, and Ptgs2. Protein levels of Sgk1, Dusp1, and Iκβ-α showed only partial agreement with transcriptional patterns, stressing the importance of assessing downstream translation when investigating rapid gene responses. Conclusion: The present study demonstrates that psilocybin rapidly…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Psilocybin stimulated the expression of IEGs in the PFC, and induced stimulating and inhibiting effects in the hippocampus (55).”
From Psychedelics and Neuroplasticity: A Systematic Review Unraveling the Biological Underpinnings of Psychedelics. (2021) · cites this paper as [55]
In the citing paper
“Moreover, in both areas, most IEGs were affected in a dose-dependent manner, with higher doses inducing more stimulation of gene expression (55).”
From Psychedelics and Neuroplasticity: A Systematic Review Unraveling the Biological Underpinnings of Psychedelics. (2021) · cites this paper as [55]
In the citing paper
“A single dose of psilocybin (0.5, 1, 2, 4, 8, 14, 20 mg/kg, i.p.) administered to rats (n = 10) altered the expression of plasticity-promoting genes in the prefrontal cortex (PFC) and hippocampus, 90 min after treatment (55).”
From Psychedelics and Neuroplasticity: A Systematic Review Unraveling the Biological Underpinnings of Psychedelics. (2021) · cites this paper as [55]
In the citing paper
“Findings from in vivo studies investigating acute effects of a single dose of 5-MeO-DMT, DMT, psilocybin, and LSD (37%) suggest altered cellular plasticity of structural and functional nature (54–60).”
From Psychedelics and Neuroplasticity: A Systematic Review Unraveling the Biological Underpinnings of Psychedelics. (2021) · cites this paper as [55]
In the citing paper
“preclinical evidence suggests a dose-dependent effect on increases in the expression of some neuroplasticity-related genes induced by serotonergic psychedelics [73–75]”
Citations
Cites
Global quantification of mammalian gene expression control
Schwanhäusser, B., Busse, D., Li, N., Dittmar, G., Schuchhardt, J., Wolf, J., Chen, W., & Selbach, M. (2011) · Nature · doi:10.1038/nature10098 · Cited by 6,566 · cited 1×
“This incongruity is not surprising considering that translation is regulated by a plethora of post-transcriptional mechanisms, and the general correlation between transcriptional and translational responses is usually modest (Schwanhausser et al., 2011).”
BackgroundA Simple Practice Guide for Dose Conversion between Animals and Human
Nair, A., & Jacob, S. (2016) · Journal of Basic and Clinical Pharmacy · doi:10.4103/0976-0105.177703 · Cited by 6,174 · cited 1×
“2 from humans to rats (Nair and Jacob, 2016), resulting in a corresponding dose of ∽2 mg/kg for rats.”
BackgroundShared Principles in NF-κB Signaling
Hayden, M. S., & Ghosh, S. (2008) · Cell · doi:10.1016/j.cell.2008.01.020 · Cited by 4,494
Griffiths, R. R., Johnson, M. W., Carducci, M. A., Umbricht, A., Richards, W. A., Richards, B. D., Cosimano, M. P., & Klinedinst, M. A. (2016) · Journal of Psychopharmacology · doi:10.1177/0269881116675513 · Cited by 2,201
Pazos, A., & Palacios, J. M. (1985) · Brain Research · doi:10.1016/0006-8993(85)90856-x · Cited by 1,855 · cited 3×
“c-Fos has been widely used as a marker of neuronal activity (Kovacs, 1998), and the present findings therefore indicate that psilocybin induces strong neuronal activation in the PFC, but not in the HIP, consistent with electrophysiological studies and receptor distributions between regions (Aghajanian and Marek, 1999;…”
BackgroundRoss, S., Bossis, A., Guss, J., Agin-Liebes, G., Malone, T., Cohen, B., Mennenga, S. E., Belser, A., Kalliontzi, K., Babb, J., et al. (2016) · Journal of Psychopharmacology · doi:10.1177/0269881116675512 · Cited by 1,698 · cited 2×
“In humans, these acute effects are followed by long-lasting positive effects on clinical symptoms (Bogenschutz et al., 2015; Carhart-Harris et al., 2016, 2018; Griffiths et al., 2016; Grob et al., 2011; Johnson et al., 2014, 2017; Moreno et al., 2006; Ross et al., 2016) and psychological features (Erritzoe et al.”
BackgroundNeurocircuitry of Mood Disorders
Price, J. L., & Drevets, W. C. (2010) · Neuropsychopharmacology · doi:10.1038/npp.2009.104 · Cited by 1,606 · cited 1×
“, 1985) also implicated in the pathophysiology of depression (Price and Drevets, 2010).”
BackgroundCarhart-Harris, R. L., Bolstridge, M., Rucker, J., Day, C. M. J., Erritzoe, D., Kaelen, M., Bloomfield, M., Rickard, J. A., Forbes, B., Feilding, A., et al. (2016) · The Lancet Psychiatry · doi:10.1016/s2215-0366(16)30065-7 · Cited by 1,540
MAPK cascade signalling and synaptic plasticity
Thomas, G. M., & Huganir, R. L. (2004) · Nature Reviews Neuroscience · doi:10.1038/nrn1346 · Cited by 1,454 · cited 1×
“Paradoxically, each of these genes has been linked to both promotion and deterioration of synaptic plasticity, possibly depending on whether the activation is acute or chronic (Alberini et al., 1994; Anacker et al., 2013; Bridi et al., 2017; Duric et al., 2010; Jeanneteau et al., 2010, 2018; Thomas and Huganir, 2004).”
BackgroundPSD-95 Involvement in Maturation of Excitatory Synapses
El-Husseini, A. E.-D., Schnell, E., Chetkovich, D. M., Nicoll, R. A., & Bredt, D. S. (2000) · Science · doi:10.1126/science.290.5495.1364 · Cited by 1,303 · cited 1×
“, 2003; Lopez-Gimenez and Gonzalez-Maeso, 2018); (c) transcriptional regulation of synaptic plasticity (Alberini, 2009; El-Husseini et al., 2000); or (d) transcriptional effects of anti-depressive treatments (Bramham et al.”
Background
Research works printed but not linked: 2
- Almaula N, 1996, Mol Pharmacol, 50, 34
- Johnson MP, 1994, Mol Pharmacol, 45, 277
Cited by
Items 101–139 of 139
Epigenome-wide association study of psilocybin-induced methylome changes in alcohol use disorder
Urban, M. M., Zillich, E., Rieser, N. M., Herdener, M., Spanagel, R., Vollenweider, F. X., Preller, K. H., & Meinhardt, M. W. (2026) · Translational Psychiatry · doi:10.1038/s41398-026-03961-3 · Cited by 2
Lodetti, G., Réus, G. Z., & Rico, E. P. (2026) · Neuroscience · doi:10.1016/j.neuroscience.2026.01.022 · Cited by 1
Blocking 5-HT2B receptors abolishes psilocybin’s efficacy in the rat forced swim test
Seillier, L., Seillier, A., Zvolska, M. A., & Šlamberová, R. (2026) · Journal of Psychopharmacology · doi:10.1177/02698811261458349 · Cited by 1
Cellular mechanisms of serotonergic psychedelics - apical hypercontextualisation
Kaup, K., Jiménez, J. H., & Aru, J. (2026) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2026.106876 · Cited by 3
Gudmundsen, F., Czurylo, J., Rijsketic, D. R., Vo, C. T., Ruuska, J., Jessen, N. S., Woodruff, S., Baun, C., Herth, M. M., Shalgunov, V., et al. (2026) · Nature Communications · doi:10.1038/s41467-026-75890-0 · Cited by 1
“…receptor dimerization 30 , induces neuronal spinogenesis in vitro and in vivo 32 , promotes dendritic growthinmice 33 ,alterstheexpressionofplasticity-promotinggenesin rat brain 34 , and increases density of the neuronal presynaptic marker synaptic vesicle glycoprotein 2A in rats 16 and pigs 35 .”
Neuropharmacological analysis of the anti-addictive and therapeutic effects of psilocybin
Principe, A. (2022) · SURG Journal · doi:10.21083/surg.v14i1.6870 · Cited by 2
Medical Use of Cannabinoids and Psychedelic Compounds
Inserra, A., Gregorio, D. D., & Gobbi, G. (2023) · Springer eBooks · doi:10.1007/978-3-030-42825-9_141-1 · Cited by 1
Morales‐Mulia, S., Díaz-Ramírez, A., Almazán‐Alvarado, S., Pérez-Luna, J. M., Hernández‐Fonseca, K., & Morales‐Mulia, M. (2024) · Research Square · doi:10.21203/rs.3.rs-4224592/v1 · Cited by 1
Chafee, H. (2022) · Open Access Victoria University of Wellington | Te Herenga Waka (Figshare) · doi:10.26686/wgtn.19579795
Medical Use of Cannabinoids and Psychedelic Compounds
Inserra, A., Gregorio, D. D., & Gobbi, G. (2023) · Springer eBooks · doi:10.1007/978-3-030-42825-9_141-2
Medical Use of Cannabinoids and Psychedelic Compounds
Inserra, A., Gregorio, D. D., & Gobbi, G. (2024) · Springer eBooks · doi:10.1007/978-3-030-51366-5_141 · Cited by 1
The Fascinating Link between Psychedelics and Neuroplasticity
Concerto, C., Lanza, G., & Rodolico, A. (2024) · Journal of Integrative Neuroscience · doi:10.31083/j.jin2309177
Yang, H. O. (2025) · Theoretical and Natural Science · doi:10.54254/2753-8818/2024.19865
Microdosing Psychedelics for Cognitive Enhancement: A Naturalistic Exploration of User Experiences
Pelham, L. (2025) · Open Access Victoria University of Wellington | Te Herenga Waka (Figshare) · doi:10.26686/tvwc-80bg
Changing minds: bioethical dimensions of psychedelic-assisted psychotherapy
Jacobs, E. (2025) · Oxford University Research Archive (ORA) (University of Oxford) · doi:10.5287/ora-qq0qxrok6
Psilosybiinin vaikutus neuroplastisiteettiin
Anttonen, P., & Ylönen, E. (2024) · UTUPub (University of Turku)
Meccia, J. (2023) · eScholarship@McGill (McGill) · doi:10.82308/31606
Effects of Serotonergic Psychedelics on Synaptic Function and Neuroplasticity
Petrušková, A. (2026) · OPUS FAU (Kooperativer Bibliotheksverbund Berlin-Brandenburg (KOBV), on behalf of the Universitätsbibliothek Erlangen-Nürnberg) · doi:10.25593/open-fau-2619
Kolbman, N. (2025) · Deep Blue (University of Michigan) · doi:10.7302/28132
Banzato, M., Colognesi, M., Lucatello, L., Comai, S., Pasut, G., Capolongo, F., Orian, L., Biasutto, L., Signor, A., Gabbia, D., et al. (2026) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5c01797 · Cited by 2
Gojani, E. G., Farzin, H., Sutherland, R. J., & Mohajerani, M. H. (2026) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2026.106619
Fiorillo, M., & González-Maeso, J. (2026) · BMC Neuroscience · doi:10.1186/s12868-026-01003-8
“…regions [100], psychedelics still elicit robust effects in this region, including anxiolysis [101], reduced hippocampal-default mode network connectivity associated with pro-plastic and therapeutic outcomes [102], and upregulation of anti-inflammatory transcripts such as Dusp1 and IκBα [103–105].”
de Oliveira, E. G. (2025) · Cross Connect (Southern Cross University) · doi:10.25918/thesis.558
Veysi, A., Atanasovski, D., Ardalan, M., Motamed, N., & Eriksson, E. (2026) · Acta Neuropsychiatrica · doi:10.1017/neu.2026.10075
“After the final handling, animals were injected subcutaneously with either saline or psilocybin (2 mg/kg) (LAB Sweden, Stockholm, Sweden) dissolved in 0.9% saline – a dose selected based on previous studies in rat (Davis and Walters, 1977; Jefsen et al. , 2021; Shahar et al. , 2022).”
InfluentialSalinsky, L. M., Fox, J. L., Diaz, K. C., Timmons, B. C., & Ferguson, S. M. (2026) · Research Square · doi:10.21203/rs.3.rs-9306429/v1
“In contrast, psilocybin was given 24-hours prior to testing, at a timepoint that engages sustained neuroplasticity-related mechanisms within cortical circuits 21–23 .”
Ahmadian-Moghadam, S., Roshan‐Milani, S., & Saboory, E. (2026) · Translational Psychiatry · doi:10.1038/s41398-026-04151-x
Jalalian-Javadpour, M., Yekta, B. G., Reyhani, N., Hajizamani, S., Azizi, A., Azad, N. K., Mohammadi, H., & Vaseghi, S. (2026) · Journal of Affective Disorders Reports · doi:10.1016/j.jadr.2026.101098
Du, Y. J., Zhao, X., Yao, Y., Li, Y., Wang, G., & Zhang, L. (2026) · Journal of Psychopharmacology · doi:10.1177/02698811261453819
Bertocchi, U., Katz, E., Jeffet, J., Grunwald, A., Gabay, N., Deek, J., Verma, S., Shwartz, A., Umschweif-Nevo, G., Lerer, B., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.07.08.736699 · Cited by 1
“…the acute serotonergic response resolves within hours of administration, and prior transcriptomic studies show that gene expression changes associated with synaptic remodeling stabilize within this window, making it appropriate for capturing the consolidation of epigenetic changes(22, 43, 51, 52).”
Wawrzczak‐Bargieła, A., Jelonek-Kozioł, M., Kumorek, W., Bilecki, W., & Maćkowiak, M. (2026) · Psychopharmacology · doi:10.1007/s00213-026-07132-6
McConnell, P. A., Raffety, J., Li, A., Steinberg, E., Rahim, S., Valtierra, C., Gazzaley, A. H., Carhart-Harris, R. L., & Pasquini, L. (2026) · Translational Psychiatry · doi:10.1038/s41398-026-04349-z
“Because these maps are derived from AHBA transcriptomic data, the results re fl ect correlative spatial alignment rather than direct measures of receptor density or receptor-speci fi c regulation.”
O'Shea, A., Mason, N. L., Schreiber, R., Verheijen, M. C. T., Ramaekers, J. G., Briedé, J. J., & Krauskopf, J. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.08.04.742716
Shahar, O., Botvinnik, A., Chaykin, M., Shwartz, A., Lerer, E., Golding, P., Ari, M. B., Shalev, O., Lifschytz, T., & Lerer, B. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.08.06.743248
Gattuso, J. J., Bezcioglu, B., Hendey, J., Payet, J. M., Phelan, Z. J., Hale, M. W., Hannan, A. J., & Renoir, T. (2026) · Molecular Psychiatry · doi:10.1038/s41380-026-03879-8 · Cited by 1
Savino, A., Liaci, C., Merlo, G. R., Prandi, L., Avalle, L., & Poli, V. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.09.11.751070
González-Hernández, G., Rozov, S. V., Berrocoso, E., & Rantamäki, T. (2026) · Neuropharmacology · doi:10.1016/j.neuropharm.2026.111221
Cheng, F., Lin, C., Chen, S., & Wang, X. (2026) · Psychedelics. · doi:10.61373/pp026w.0009
Lerer, E., Botvinnik, A., Shahar, O., Grad, M., Blakolmer, K., Shomron, N., Lotan, A., Lerer, B., & Lifschytz, T. (2024) · doi:10.3389/fphar.2024.1391412.s001
Supporting information 1 of Acute psilocybin increased cortical activities in rats
Liu, J., Wang, Y., Xia, K., Wu, J., Zheng, D., Cai, A., Yan, H., & Su, R. (2023) · doi:10.3389/fnins.2023.1168911.s001
Metadata
- Authors
- Jefsen, O. H., Elfving, B., Wegener, G., & Müller, H. K.
- Affiliations
- Aarhus University (DK)
- Corresponding author
- Jefsen, Oskar Hougaard
- Venue
- Journal of Psychopharmacology
- Publisher
- SAGE Publications
- Published
- 2020-11-04
- Volume
- 35
- Issue
- 4
- Pages
- 483-493
- ISSN
- 0269-8811 (ISSN-L)
- 1461-7285
- OpenAlex
- W3094714065
- Semantic Scholar
- bed49b948ad75bafb93f76f7d68ec15f3dd554c7
- Cited by
- 127
- References
- 71
- Citations by year
- 2026: 21 · 2025: 26 · 2024: 31 · 2023: 20 · 2022: 11 · 2021: 16 · 2020: 1
- FWCI
- 4.76
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- journals.sagepub.com/page/policies/text-and-data-mining-license (tdm)
- Locations
- Journal of Psychopharmacology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Det Frie Forskningsråd (DFF-7025-00041)
- Solar Fonden af 1978
- Fonden til Lægevidenskabens Fremme
- Direktør Emil C. Hertz og Hustru Inger Hertz Fond
- Dagmar Marshalls Fond
- Torben og Alice Frimodts Fond
- Lundbeckfonden (R-197-2016-1730)
- Topics
- Social Sciences › Psychology › Clinical Psychology › Psychedelics and Drug Studies
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Keywords
- psilocybin, psychedelics, transcriptional regulation, prefrontal cortex, hippocampus, immediate early genes, neuroplasticity, gene expression, mRNA translation, SGK1, MKP-1, Arc, CLK1, dose-dependent effects, serotonergic psychedelics
- MeSH terms
- Animals, Cytoskeletal Proteins, Dose-Response Relationship, Drug, Gene Expression Regulation, Hallucinogens, Hippocampus, Nerve Tissue Proteins, Neuronal Plasticity, Psilocybin, Genes, fos, Rats, Sprague-Dawley, Prefrontal Cortex, Genes, Immediate-Early, Rats, Early Growth Response Protein 2
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.